Vansteenkiste J - Search Results

1

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, Martinez Aguillo M, Aerts J, Govindan R, Rubio-Viqueira B, Lewanski C, Gandara D, Choy H, Mok T, Hossain A, Iscoe N, Treat J, Koustenis A, San Antonio B, Chouaki N, Vokes E. Senan S, et al. Among authors: vansteenkiste j. J Clin Oncol. 2016 Mar 20;34(9):953-62. doi: 10.1200/JCO.2015.64.8824. Epub 2016 Jan 25. J Clin Oncol. 2016. PMID: 26811519 Clinical Trial.

2

Surgical treatment of small cell lung cancer.

Coolen L, Van den Eeckhout A, Deneffe G, Demedts M, Vansteenkiste J. Coolen L, et al. Among authors: vansteenkiste j. Eur J Cardiothorac Surg. 1995;9(2):59-64. doi: 10.1016/s1010-7940(05)80018-1. Eur J Cardiothorac Surg. 1995. PMID: 7748573

3

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.

Simons JP, Aaronson NK, Vansteenkiste JF, ten Velde GP, Muller MJ, Drenth BM, Erdkamp FL, Cobben EG, Schoon EJ, Smeets JB, Schouten HC, Demedts M, Hillen HF, Blijham GH, Wouters EF. Simons JP, et al. Among authors: vansteenkiste jf. J Clin Oncol. 1996 Apr;14(4):1077-84. doi: 10.1200/JCO.1996.14.4.1077. J Clin Oncol. 1996. PMID: 8648360 Clinical Trial.

4

Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.

Vansteenkiste J, Vandebroek J, Mariën S, Roex L, Bertrand P, Bockaert J, De Beukelaar T, Deman R, De Muynck P, Ulrichts H, et al. Vansteenkiste J, et al. Lung Cancer. 1995 Dec;13(3):295-303. doi: 10.1016/0169-5002(95)00502-1. Lung Cancer. 1995. PMID: 8719069 Clinical Trial.

5

Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.

Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, Demedts MG. Vansteenkiste JF, et al. Ann Thorac Surg. 1997 May;63(5):1441-50. doi: 10.1016/s0003-4975(97)00314-7. Ann Thorac Surg. 1997. PMID: 9146340

6

Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.

Vansteenkiste JF, De Leyn PR, Deneffe GJ, Lievens YN, Nackaerts KL, Van Raemdonck DE, van der Schueren E, Lerut TE, Demedts MG. Vansteenkiste JF, et al. Ann Oncol. 1998 Mar;9(3):261-7. doi: 10.1023/a:1008240127706. Ann Oncol. 1998. PMID: 9602259 Clinical Trial.

7

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA, Demedts MG. Vansteenkiste JF, et al. J Clin Oncol. 1998 Jun;16(6):2142-9. doi: 10.1200/JCO.1998.16.6.2142. J Clin Oncol. 1998. PMID: 9626214

8

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group.

Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verbeken EK. Vansteenkiste JF, et al. Ann Oncol. 1998 Nov;9(11):1193-8. doi: 10.1023/a:1008437915860. Ann Oncol. 1998. PMID: 9862049 Free article. Clinical Trial.

9

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group.

Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Mortelmans LA, Demedts MG. Vansteenkiste JF, et al. J Clin Oncol. 1999 Oct;17(10):3201-6. doi: 10.1200/JCO.1999.17.10.3201. J Clin Oncol. 1999. PMID: 10506619

10

The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.

Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ. Vanuytsel LJ, et al. Among authors: vansteenkiste jf. Radiother Oncol. 2000 Jun;55(3):317-24. doi: 10.1016/s0167-8140(00)00138-9. Radiother Oncol. 2000. PMID: 10869746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page